Screener
Krystal Biotech, Inc. KRYS Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands) | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Effect of exchange rate changes on cash and cash equivalents | (1,331) | 171 |
| Net increase (decrease) in cash and cash equivalents | 5,009 | (36,095) |
| Cash and cash equivalents at beginning of period | 496,304 | 344,865 |
| Cash and cash equivalents at end of period | $501,313 | $308,770 |
| Supplemental Disclosures of Non-Cash Activities | ||
| Unpaid purchases of property and equipment | $1,218 | $1,397 |
| Initial recognition of right-of-use assets | — | $1,802 |
| Supplemental Cash Flow Information |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s cash & equivalents?
- Krystal Biotech, Inc. (KRYS) reported cash & equivalents of $501.31M in Q1 2026.
- How has Krystal Biotech, Inc.'s cash & equivalents changed year-over-year?
- Krystal Biotech, Inc.'s cash & equivalents increased by 62.4% year-over-year, from $308.77M to $501.31M.
- What is the long-term trend for Krystal Biotech, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s cash & equivalents has grown at a 13.1% compound annual growth rate (CAGR), from $268.27M to $496.3M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Krystal Biotech, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude